One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the STENT PAMI trial

OBJECTIVE - This analysis was undertaken to determine the composite incidence of cumulative adverse events (death, reinfarction, disabling stroke, and target vessel revascularization) at the end of the first year after acute myocardial infarction, in diabetic patients who underwent coronary stenting...

Full description

Bibliographic Details
Main Authors: Luiz Alberto Mattos, Cindy L. Grines, J. Eduardo de Sousa, Amanda G. M. R. Sousa, Gregg W. Stone, David Cox, Eulogio Garcia, Marie-Claude Morice, William O'Neill, Lorelei Grines, Judith Boura
Format: Article
Language:English
Published: Sociedade Brasileira de Cardiologia (SBC) 2001-12-01
Series:Arquivos Brasileiros de Cardiologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2001001200006
id doaj-aa21d15acf1041c99c3d1244a84ddff6
record_format Article
spelling doaj-aa21d15acf1041c99c3d1244a84ddff62020-11-25T01:00:54ZengSociedade Brasileira de Cardiologia (SBC)Arquivos Brasileiros de Cardiologia0066-782X1678-41702001-12-0177655656110.1590/S0066-782X2001001200006One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the STENT PAMI trialLuiz Alberto MattosCindy L. GrinesJ. Eduardo de SousaAmanda G. M. R. SousaGregg W. StoneDavid CoxEulogio GarciaMarie-Claude MoriceWilliam O'NeillLorelei GrinesJudith BouraOBJECTIVE - This analysis was undertaken to determine the composite incidence of cumulative adverse events (death, reinfarction, disabling stroke, and target vessel revascularization) at the end of the first year after acute myocardial infarction, in diabetic patients who underwent coronary stenting or primary coronary balloon angioplasty. METHODS - From the STENT PAMI trial, we analyzed the 6-month angiographic and 1-year clinical outcomes of 135 diabetic (112, noninsulin dependent) patients who underwent the randomization process of the trial and compared them with 758 nondiabetic patients. RESULTS - Coronary stenting did not significantly reduce the primary composite clinical end point when compared with PTCA (20 vs. 30%, p=0.2). A significant benefit from stenting was observed in patients with noninsulin dependent diabetes, with a trend toward a lesser need for new revascularization procedures (10 vs. 21%, p<.001), with a significant reduction in the primary composite clinical end point at 1 year (12 vs. 28%, p=. 04). At 6 months, the restenosis rate were significantly reduced only in nondiabetic patients (18 vs. 33%, p<. 001). Diabetic patients had the same restenosis rate (38%) either with stenting or balloon PTCA. CONCLUSIONS - Coronary Stenting in diabetics noninsulin dependent offered a significant reduction in the composite incidence of major clinical adverse events compared with balloon PTCA.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2001001200006myocardial infarctionstentsdiabetes mellitus
collection DOAJ
language English
format Article
sources DOAJ
author Luiz Alberto Mattos
Cindy L. Grines
J. Eduardo de Sousa
Amanda G. M. R. Sousa
Gregg W. Stone
David Cox
Eulogio Garcia
Marie-Claude Morice
William O'Neill
Lorelei Grines
Judith Boura
spellingShingle Luiz Alberto Mattos
Cindy L. Grines
J. Eduardo de Sousa
Amanda G. M. R. Sousa
Gregg W. Stone
David Cox
Eulogio Garcia
Marie-Claude Morice
William O'Neill
Lorelei Grines
Judith Boura
One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the STENT PAMI trial
Arquivos Brasileiros de Cardiologia
myocardial infarction
stents
diabetes mellitus
author_facet Luiz Alberto Mattos
Cindy L. Grines
J. Eduardo de Sousa
Amanda G. M. R. Sousa
Gregg W. Stone
David Cox
Eulogio Garcia
Marie-Claude Morice
William O'Neill
Lorelei Grines
Judith Boura
author_sort Luiz Alberto Mattos
title One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the STENT PAMI trial
title_short One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the STENT PAMI trial
title_full One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the STENT PAMI trial
title_fullStr One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the STENT PAMI trial
title_full_unstemmed One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the STENT PAMI trial
title_sort one-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients: a substudy of the stent pami trial
publisher Sociedade Brasileira de Cardiologia (SBC)
series Arquivos Brasileiros de Cardiologia
issn 0066-782X
1678-4170
publishDate 2001-12-01
description OBJECTIVE - This analysis was undertaken to determine the composite incidence of cumulative adverse events (death, reinfarction, disabling stroke, and target vessel revascularization) at the end of the first year after acute myocardial infarction, in diabetic patients who underwent coronary stenting or primary coronary balloon angioplasty. METHODS - From the STENT PAMI trial, we analyzed the 6-month angiographic and 1-year clinical outcomes of 135 diabetic (112, noninsulin dependent) patients who underwent the randomization process of the trial and compared them with 758 nondiabetic patients. RESULTS - Coronary stenting did not significantly reduce the primary composite clinical end point when compared with PTCA (20 vs. 30%, p=0.2). A significant benefit from stenting was observed in patients with noninsulin dependent diabetes, with a trend toward a lesser need for new revascularization procedures (10 vs. 21%, p<.001), with a significant reduction in the primary composite clinical end point at 1 year (12 vs. 28%, p=. 04). At 6 months, the restenosis rate were significantly reduced only in nondiabetic patients (18 vs. 33%, p<. 001). Diabetic patients had the same restenosis rate (38%) either with stenting or balloon PTCA. CONCLUSIONS - Coronary Stenting in diabetics noninsulin dependent offered a significant reduction in the composite incidence of major clinical adverse events compared with balloon PTCA.
topic myocardial infarction
stents
diabetes mellitus
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2001001200006
work_keys_str_mv AT luizalbertomattos oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial
AT cindylgrines oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial
AT jeduardodesousa oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial
AT amandagmrsousa oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial
AT greggwstone oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial
AT davidcox oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial
AT eulogiogarcia oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial
AT marieclaudemorice oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial
AT williamoneill oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial
AT loreleigrines oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial
AT judithboura oneyearfollowupafterprimarycoronaryinterventionforacutemyocardialinfarctionindiabeticpatientsasubstudyofthestentpamitrial
_version_ 1725212118267985920